Bruno Tocqué

2.9k total citations
64 papers, 2.4k citations indexed

About

Bruno Tocqué is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Bruno Tocqué has authored 64 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 19 papers in Oncology and 8 papers in Organic Chemistry. Recurrent topics in Bruno Tocqué's work include Protein Kinase Regulation and GTPase Signaling (22 papers), Cancer-related Molecular Pathways (9 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). Bruno Tocqué is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (22 papers), Cancer-related Molecular Pathways (9 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). Bruno Tocqué collaborates with scholars based in France, United States and Spain. Bruno Tocqué's co-authors include Fabien Schweighoffer, Fabienne Parker, Marc Duchesne, Isabelle Delumeau, Isabelle Barlat, Florence Maurier, Marie-Christine Multon, Laurent Debüssche, Véronique Leblanc and Martine Pomérance and has published in prestigious journals such as Science, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Bruno Tocqué

64 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruno Tocqué France 28 1.9k 488 393 179 176 64 2.4k
V M Garsky United States 23 1.7k 0.9× 546 1.1× 246 0.6× 244 1.4× 160 0.9× 37 2.5k
Ingrid Remy Canada 14 1.6k 0.8× 300 0.6× 388 1.0× 207 1.2× 103 0.6× 15 2.2k
I. Hiles United Kingdom 12 2.1k 1.1× 482 1.0× 585 1.5× 399 2.2× 104 0.6× 12 2.6k
Christian R. Lombardo United States 19 1.6k 0.8× 321 0.7× 397 1.0× 211 1.2× 299 1.7× 26 2.3k
Andrew W. Brauer United States 13 1.6k 0.8× 286 0.6× 333 0.8× 287 1.6× 66 0.4× 14 2.3k
C. Chandra Kumar United States 24 1.8k 0.9× 449 0.9× 300 0.8× 218 1.2× 322 1.8× 43 2.5k
Markus Boehm United States 25 1.7k 0.9× 359 0.7× 748 1.9× 201 1.1× 176 1.0× 55 2.5k
R Clark United States 19 1.3k 0.7× 516 1.1× 325 0.8× 93 0.5× 69 0.4× 25 1.9k
Sibo Feng United States 8 1.6k 0.8× 340 0.7× 360 0.9× 382 2.1× 59 0.3× 8 2.1k
Stig Linder Sweden 32 1.7k 0.9× 712 1.5× 265 0.7× 213 1.2× 368 2.1× 74 2.8k

Countries citing papers authored by Bruno Tocqué

Since Specialization
Citations

This map shows the geographic impact of Bruno Tocqué's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Tocqué with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Tocqué more than expected).

Fields of papers citing papers by Bruno Tocqué

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Tocqué. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Tocqué. The network helps show where Bruno Tocqué may publish in the future.

Co-authorship network of co-authors of Bruno Tocqué

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Tocqué. A scholar is included among the top collaborators of Bruno Tocqué based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Tocqué. Bruno Tocqué is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kennedy, Derek, et al.. (2001). Characterization of G3BPs: Tissue specific expression, chromosomal localisation and rasGAP120 binding studies. Journal of Cellular Biochemistry. 84(1). 173–187. 71 indexed citations
2.
Li, Xuguang, Marie-Christine Multon, Yvette Hénin, et al.. (2000). Grb3-3 Is Up-regulated in HIV-1-infected T-cells and Can Potentiate Cell Activation through NFATc. Journal of Biological Chemistry. 275(40). 30925–30933. 15 indexed citations
3.
Fromentel, Claude Caron de, Nadège Gruel, Corinne Venot, et al.. (1999). Restoration of transcriptional activity of p53 mutants in human tumour cells by intracellular expression of anti-p53 single chain Fv fragments. Oncogene. 18(2). 551–557. 67 indexed citations
4.
Pradier, Laurent, Nathalie Carpentier, Luc Buée, et al.. (1999). Mapping the APP/Presenilin (PS) Binding Domains: The Hydrophilic N-Terminus of PS2 Is Sufficient for Interaction with APP and Can Displace APP/PS1 Interaction. Neurobiology of Disease. 6(1). 43–55. 30 indexed citations
5.
Venot, Corinne, Claude Caron de Fromentel, Laurent Debüssche, et al.. (1999). A tumor specific single chain antibody dependent gene expression system. Oncogene. 18(2). 559–564. 5 indexed citations
6.
Leblanc, Véronique, Isabelle Delumeau, & Bruno Tocqué. (1999). Ras-GTPase activating protein inhibition specifically induces apoptosis of tumour cells. Oncogene. 18(34). 4884–4889. 32 indexed citations
7.
Pomérance, Martine, Marie-Christine Multon, Fabienne Parker, et al.. (1998). Grb2 Interaction with MEK-Kinase 1 Is Involved in Regulation of Jun-Kinase Activities in Response to Epidermal Growth Factor. Journal of Biological Chemistry. 273(38). 24301–24304. 43 indexed citations
8.
9.
Conseiller, Emmanuel, Laurent Debüssche, D Landais, et al.. (1998). CTS1: a p53-derived chimeric tumor suppressor gene with enhanced in vitro apoptotic properties.. Journal of Clinical Investigation. 101(1). 120–127. 27 indexed citations
10.
Saltzman, Alan, George H. Searfoss, Christophe Marcireau, et al.. (1998). hUBC9 associates with MEKK1 and type I TNF‐α receptor and stimulates NFκB activity. FEBS Letters. 425(3). 431–435. 22 indexed citations
11.
Barlat, Isabelle, et al.. (1997). A Role for Sam68 in Cell Cycle Progression Antagonized by a Spliced Variant within the KH Domain. Journal of Biological Chemistry. 272(6). 3129–3132. 86 indexed citations
12.
Parker, Fabienne, Florence Maurier, Isabelle Delumeau, et al.. (1996). A Ras-GTPase-Activating Protein SH3-Domain-Binding Protein. Molecular and Cellular Biology. 16(6). 2561–2569. 181 indexed citations
14.
Goudreau, Nathalie, F. Cornille, Marc Duchesne, et al.. (1994). NMR structure of the N-terminal SH3 domain of GRB2 and its complex with a proline-rich peptide from Sos. Nature Structural & Molecular Biology. 1(12). 898–907. 92 indexed citations
15.
Chen, Huixiong, Fabienne Parker, Patrick Mailliet, et al.. (1994). Structure-Activity Relationships in a Series of 5-[(2,5-Dihydroxybenzyl)amino]salicylate Inhibitors of EGF-Receptor-Associated Tyrosine Kinase: Importance of Additional Hydrophobic Aromatic Interactions. Journal of Medicinal Chemistry. 37(6). 845–859. 21 indexed citations
16.
Apiou, F., et al.. (1993). Identification of two human homologues toDrosophilaSOS (Son of Sevenless) localized on two different chromosomes. Nucleic Acids Research. 21(18). 4398–4398. 3 indexed citations
17.
Schweighoffer, Fabien, et al.. (1992). Implication of GAP in Ras-dependent transactivation of a polyoma enhancer sequence. Science. 256(5058). 825–827. 20 indexed citations
18.
Debüssche, Laurent, et al.. (1989). Antibodies to Synthetic Peptide from the Residue 33 to 42 Domain of c-Ha- ras p21 Block Reconstitution of the Protein with Different Effectors. Molecular and Cellular Biology. 9(9). 3904–3910. 22 indexed citations
19.
Suarez, H. G., et al.. (1988). Differential sensitivity to pertussis toxin of 3T3 cells transformed with different oncogenes. FEBS Letters. 237(1-2). 203–207. 3 indexed citations
20.
Tocqué, Bruno, et al.. (1987). The μ-opioid receptor in the 7315c tumor cell. European Journal of Pharmacology. 143(1). 127–130. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026